A San Antonio woman passionate about teaching special education with the North East Independent School District had to retire ...

The MSU is a special unit with a laboratory facility aimed at understanding the nature and cause of diseases in an urban ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in ...

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...

Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study De ...

The Move GBS Forward campaign highlights a promising new approach to treatment of the disease. Annexon Biosciences CEO Doug ...

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study ...

Brenan Cullimore had a rare genetic condition, Brugada syndrome, that led to cardiac arrest. His wife wants to raise awareness of CPR, AEDs in saving lives. In early March 2025, medical student ...

The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month this May by launching a global campaign to raise ...

This local financial advisor, husband and father of two, describes his battle with a rare disease as an ordeal that became as ...